2seventy Bio Stock Cash Flow From Operations
| TSVTDelisted Stock | USD 5.00 0.00 0.00% |
2Seventy Bio's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting 2Seventy Stock price.
2Seventy |
2Seventy Bio Company Cash Flow From Operations Analysis
2Seventy Bio's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current 2Seventy Bio Cash Flow From Operations | (85 M) |
Most of 2Seventy Bio's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, 2Seventy Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
In accordance with the recently published financial statements, 2Seventy Bio has (85 Million) in Cash Flow From Operations. This is 116.12% lower than that of the Biotechnology sector and 235.94% lower than that of the Health Care industry. The cash flow from operations for all United States stocks is 108.75% higher than that of the company.
2Seventy Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 2Seventy Bio's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of 2Seventy Bio could also be used in its relative valuation, which is a method of valuing 2Seventy Bio by comparing valuation metrics of similar companies.2Seventy Bio is currently under evaluation in cash flow from operations category among its peers.
2Seventy Fundamentals
| Return On Equity | -0.0194 | ||||
| Return On Asset | -0.0749 | ||||
| Profit Margin | (0.08) % | ||||
| Operating Margin | (0.11) % | ||||
| Current Valuation | 335.53 M | ||||
| Shares Outstanding | 53.23 M | ||||
| Shares Owned By Insiders | 6.44 % | ||||
| Shares Owned By Institutions | 82.40 % | ||||
| Number Of Shares Shorted | 2.59 M | ||||
| Price To Book | 1.24 X | ||||
| Price To Sales | 5.50 X | ||||
| Revenue | 37.86 M | ||||
| Gross Profit | (13.24 M) | ||||
| EBITDA | (115.43 M) | ||||
| Net Income | (57.25 M) | ||||
| Cash And Equivalents | 357.93 M | ||||
| Cash Per Share | 9.45 X | ||||
| Total Debt | 243.72 M | ||||
| Debt To Equity | 0.73 % | ||||
| Current Ratio | 3.88 X | ||||
| Book Value Per Share | 4.08 X | ||||
| Cash Flow From Operations | (85 M) | ||||
| Short Ratio | 2.44 X | ||||
| Earnings Per Share | (0.08) X | ||||
| Target Price | 5.0 | ||||
| Number Of Employees | 65 | ||||
| Beta | 1.05 | ||||
| Market Capitalization | 266.14 M | ||||
| Total Asset | 479.51 M | ||||
| Retained Earnings | (568.46 M) | ||||
| Working Capital | 147.16 M | ||||
| Net Asset | 479.51 M |
About 2Seventy Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze 2Seventy Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 2Seventy Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 2Seventy Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in 2Seventy Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in 2Seventy Stock
If you are still planning to invest in 2Seventy Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the 2Seventy Bio's history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |